enow.com Web Search

  1. Ads

    related to: new antipsychotic approved

Search results

  1. Results from the WOW.Com Content Network
  2. Bristol Myers wins US FDA approval for new type of ...

    www.aol.com/news/us-fda-approves-bristol-myers...

    (Reuters) -The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades. The ...

  3. FDA approves 1st new drug for schizophrenia in more ... - AOL

    www.aol.com/fda-approves-1st-drug-schizophrenia...

    The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb ...

  4. FDA approves new type of schizophrenia drug - AOL

    www.aol.com/news/fda-approves-type-schizophrenia...

    The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...

  5. List of antipsychotics - Wikipedia

    en.wikipedia.org/wiki/List_of_antipsychotics

    Antipsychotics by class Generic name Brand names Chemical class ATC code Typical antipsychotics; Acepromazine: Atravet, Acezine: phenothiazine: N05AA04

  6. Xanomeline/trospium chloride - Wikipedia

    en.wikipedia.org/wiki/Xanomeline/trospium_chloride

    In September 2024, it was approved for medical use in the United States. [1] [2] It is the first antipsychotic drug approved by the US Food and Drug Administration (FDA) to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care. [2] [3]

  7. Lumateperone - Wikipedia

    en.wikipedia.org/wiki/Lumateperone

    Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class. It is approved for the treatment of schizophrenia as well as bipolar depression, as either monotherapy or adjunctive therapy (with lithium or valproate). [2] It is developed by Intra-Cellular Therapies, licensed from Bristol ...

  8. This FDA-approved drug promises a new way to treat ... - AOL

    www.aol.com/fda-approved-drug-promises-way...

    People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug.. Studies ...

  9. Pimavanserin - Wikipedia

    en.wikipedia.org/wiki/Pimavanserin

    Unlike other antipsychotics, pimavanserin is not a dopamine receptor antagonist, [5] but rather is a selective antagonist or inverse agonist of the serotonin 5-HT 2A receptor and to a lesser extent of the serotonin 5-HT 2C receptor. [3] Pimavanserin was first approved for medical use in 2016. [3] It was approved as a generic medication in 2024. [6]

  1. Ads

    related to: new antipsychotic approved